- [ Press Releases ](/news-center/press-releases) # DynaMed® and Micromedex® with Watson™ is now DynaMedex™ ~ Solution Designed to Combine Drug and Disease Content into a Single-Source for Evidence-based Insights, Changing the Course of Care ~ ![Featured Health Care image](https://assets.ebsco.com/m/74346fad5af330d6/original/ebsco-news-center-press-releases-default-image-healthcare-780.png) **IPSWICH, Mass. — Oct. 11, 2022 —** EBSCO Information Services ([EBSCO](/health-care)) and [Merative](https://www.merative.com/) add a new face to their integrated clinical decision support solution. Under a new name, [*DynaMedex*](https://www.dynamedex.com/)™, formerly *DynaMed*® *and Micromedex® with Watson*™, continues to enhance clinical decision support and operations for healthcare providers and health systems. *DynaMedex* offers the power of combining two award-winning disease and drug solution suites — *DynaMed* and *Micromedex* — into one seamless experience. *DynaMed* quickly surfaces peer-reviewed clinical content, with recommendations supported by the latest clinical evidence from comprehensive disease topics, health conditions, and abnormal findings to highly focused topics on evaluation, differential diagnosis and management. *Micromede*x is a leading evidence-based online reference database for medication information. More than 3,300 hospitals and health systems worldwide rely on *Micromedex* to support decision-making in medication therapy management, toxicology, alternative medicine and patient education. *DynaMed* was named [2022 Best in KLAS for Clinical Decision Support](/news-center/press-releases/ebsco-dynamed-named-2022-best-klas-clinical-decision-support) for the second consecutive year and is a flagship product of EBSCO’s [Clinical Decisions](/health-care/clinical-decision-support) suite, which received Frost & Sullivan’s [2022 North America Product Leadership award](/news-center/press-releases/frost-sullivan-awards-ebsco-information-services-delivering-innovative). Since the [partnership began in March 2020](/news-center/press-releases/ibm-and-ebsco-launch-clinical-decision-support-solution), *DynaMedex* has continued to grow and increase its offerings connected to the *DynaMedex* ecosystem. With the integration of [*DynaMed Decisions*](/clinical-decisions/dynamed-solutions/dynamed-decisions), a tool designed to drive meaningful patient-clinician interactions, clinicians have easy access to additional resources to streamline their workflow and support shared decision-making. The addition of [*Isabel*](/health-care/products/isabel), a diagnostic decision support tool available in *DynaMed*, enables clinicians to experience an improved diagnosis quality, leading to cost-effective patient care. EBSCO Executive Vice President of Clinical Decisions Betsy Jones says that the solution’s new name is indicative of the company’s intent to move the resource forward as EBSCO Clinical Decisions’ new flagship product. “More than two years into our partnership with *Micromedex*, we continue to see the value of *DynaMedex* and how the combined solution benefits all clinicians across the continuum of care. *DynaMedex* will continue to serve as a one-stop-shop for clinicians at the point of care.” *DynaMed* Editor in Chief Peter Oettgen, MD, FACC, FAHA, FACP, says that the breadth and depth of the evidence-based content available in *DynaMedex* has grown tremendously in the last few years. “With *DynaMedex*, clinicians have access to the most current drug and disease content, extensive coverage of specialty topics, and recommendations that are based on the latest evidence and clinical practice guidelines, providing decision support when they need it.” With the leading drug information resources, together with the most current disease and condition topics, across the most specialties and unique tools for differential diagnosis and shared-decision-making, *DynaMedex* is not just a name change, it is the beginning of a new era in clinical care. For more information on *DynaMedex*, visit [www.dynamedex.com](http://www.dynamedex.com). **About EBSCO Information Services** EBSCO Information Services (EBSCO) is the preeminent provider of online research content and search technologies serving academic, school and public libraries; healthcare and medical institutions; corporations; and government agencies around the world. EBSCO’s Clinical Decisions suite of products is designed to improve patient care by providing healthcare professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care. For more information, visit the EBSCO website at: [www.ebsco.com](http://www.ebsco.com). \### **For more information, please contact:** Jessica Holmes EBSCO Information Services Communications Director 978-414-0420 Share this: - [Facebook](https://www.facebook.com/sharer.php?u=https://about.ebsco.com/markdownify/node/82789) - [Twitter]() - [LinkedIn]()